Plea For Contributory Infringement Struck As Not A Cause Of Action (Intellectual Property Weekly Abstracts Bulletin - Week of July 2, 2012)

BL
Borden Ladner Gervais LLP

Contributor

BLG is a leading, national, full-service Canadian law firm focusing on business law, commercial litigation, and intellectual property solutions for our clients. BLG is one of the country’s largest law firms with more than 750 lawyers, intellectual property agents and other professionals in five cities across Canada.
The Court of Appeal found no error in the decision of the Court that contributory infringement is not a cause of action.
Canada Intellectual Property

Actions

Plea for Contributory Infringement Struck as Not a Cause of Action
Nycomed Canada Inc. v. Teva Canada Limited

The Court of Appeal found no error in the decision of the Court that contributory infringement is not a cause of action. The Court had struck this plea in the statement of defence and counterclaim on the basis that it was plain and obvious that the plea would fail. A copy of the Federal Court decision can be found here. A copy of our summary can be found here. The Court of Appeal dismissed the appeals.

Other Cases of Interest

Prejudgment Interest Awarded in Election of Statutory Damages
Society of Composers, Authors and Music Publishers of Canada v. IIC Enterprises Ltd. (Cheetah's Nightclub)

The Court of Appeal considered the finding by the Prothonotary, and upheld by the Federal Court, that SOCAN was not entitled to prejudgment interest in light of its election for statutory damages. A copy of the Federal Court decision can be found here. A copy of our summary can be found here. The Court of Appeal allowed the appeal and granted prejudgment interest, finding that SOCAN's entitlement was determined by the law of British Columbia.

Industry News

Bill C-11, The Copyright Modernization Act has received Royal Assent.

The Patented Medicine Prices Review Board released its 2010 Compendium of Policies, Guidelines and Procedures.

Health Canada has announced the launch of Phase II of the Summary Basis of Decision (SBD) project. Along with the notice, it has also published a Frequently Asked Questions document and Reader's Guides to the SBD for Drugs and for Medical Devices.

Health Canada has also published a new approach to Natural Health Products.

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More